| Bioactivity | Coblopasvir (KW-136) dihydrochloride is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir dihydrochloride can be used for research of chronic hepatitis C virus infection[1]. |
| Name | Coblopasvir dihydrochloride |
| CAS | 1966138-53-3 |
| Formula | C41H52Cl2N8O8 |
| Molar Mass | 855.81 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Gao Y, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial. Liver Int. 2020;40(11):2685-2693. |
Coblopasvir dihydrochloride
CAS: 1966138-53-3 F: C41H52Cl2N8O8 W: 855.81
Coblopasvir (KW-136) dihydrochloride is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir dihydroch
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.